Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-050688
Filing Date
2022-04-27
Accepted
2022-04-27 08:02:51
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223678d2_defa14a.htm DEFA14A 15521
2 GRAPHIC tm223678d2_defa14aimg001.jpg GRAPHIC 1561764
3 GRAPHIC tm223678d2_defa14aimg002.jpg GRAPHIC 112579
  Complete submission text file 0001104659-22-050688.txt   2320875
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37467 | Film No.: 22856419
SIC: 2834 Pharmaceutical Preparations